These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24381724)

  • 21. Cracking the combination: Gut hormones for the treatment of obesity and diabetes.
    Alexiadou K; Anyiam O; Tan T
    J Neuroendocrinol; 2019 May; 31(5):e12664. PubMed ID: 30466162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
    Federico A; Dallio M; Tolone S; Gravina AG; Patrone V; Romano M; Tuccillo C; Mozzillo AL; Amoroso V; Misso G; Morelli L; Docimo L; Loguercio C
    In Vivo; 2016; 30(3):321-30. PubMed ID: 27107092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal hormones and regulation of food intake.
    Dhillo WS; Bloom SR
    Horm Metab Res; 2004; 36(11-12):846-51. PubMed ID: 15655718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.
    Schiellerup SP; Skov-Jeppesen K; Windeløv JA; Svane MS; Holst JJ; Hartmann B; Rosenkilde MM
    Front Endocrinol (Lausanne); 2019; 10():75. PubMed ID: 30863364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake.
    Elliott JA; Reynolds JV; le Roux CW; Docherty NG
    Expert Rev Endocrinol Metab; 2016 Nov; 11(6):475-499. PubMed ID: 30058920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapies in the treatment of 'diabesity': beyond GLP-1.
    Tharakan G; Tan T; Bloom S
    Trends Pharmacol Sci; 2011 Jan; 32(1):8-15. PubMed ID: 21130506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat.
    Abbott CR; Small CJ; Sajedi A; Smith KL; Parkinson JR; Broadhead LL; Ghatei MA; Bloom SR
    Int J Obes (Lond); 2006 Feb; 30(2):288-92. PubMed ID: 16231018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy.
    Khoo B; Tan TM
    J Endocrinol; 2020 Sep; 246(3):R65-R74. PubMed ID: 32438346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut hormones: a weight off your mind.
    Gardiner JV; Jayasena CN; Bloom SR
    J Neuroendocrinol; 2008 Jun; 20(6):834-41. PubMed ID: 18601707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
    Jones B; Sands C; Alexiadou K; Minnion J; Tharakan G; Behary P; Ahmed AR; Purkayastha S; Lewis MR; Bloom S; Li JV; Tan TM
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e767-e782. PubMed ID: 34460933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
    Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
    Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.
    Perez-Tilve D; Nogueiras R; Mallo F; Benoit SC; Tschoep M
    Endocrine; 2006 Feb; 29(1):61-71. PubMed ID: 16622293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxyntomodulin : a novel potential treatment for obesity.
    Druce MR; Bloom SR
    Treat Endocrinol; 2006; 5(5):265-72. PubMed ID: 17002486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature.
    Lampropoulos C; Alexandrides T; Tsochatzis S; Kehagias D; Kehagias I
    Obes Surg; 2021 Oct; 31(10):4575-4584. PubMed ID: 34304379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
    Holst JJ
    Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Regulation of Peripheral Metabolism by Gut-Derived Hormones.
    Sun EWL; Martin AM; Young RL; Keating DJ
    Front Endocrinol (Lausanne); 2018; 9():754. PubMed ID: 30662430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years.
    Rose F; Bloom S; Tan T
    Expert Opin Drug Discov; 2019 Nov; 14(11):1151-1159. PubMed ID: 31355685
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.
    Behary P; Cegla J; Tan TM; Bloom SR
    Postgrad Med; 2015 Jun; 127(5):494-502. PubMed ID: 26040552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.